That not only downregulation but also upregulation can be associated with tumor progression in a tumor type dependent manner is demonstrated in our study by the strong relationship between CLDN3 upregulation and grade and stage progression in urothelial carcinomas. Here, CLDN3 is linked to urothelial carcinoma.